AtriCure (ATRC) Gains from Investment Securities (2014 - 2021)

AtriCure (ATRC) has 6 years of Gains from Investment Securities data on file, last reported at $184.8 million in Q3 2021.

• On a quarterly basis, Gains from Investment Securities rose 96150.0% year-over-year to $184.8 million in Q3 2021; TTM through Jun 2022 was $184.8 million, a 1787.83% increase from a year earlier, with the FY2021 full-year figure at -$184.8 million, down 51664.71% from the prior year.
• Gains from Investment Securities for Q3 2021 stood at $184.8 million, up from $2.6 million in the prior quarter.
• Over the last five years, Gains from Investment Securities for ATRC reached as high as $184.8 million in Q3 2021 and fell as low as -$7.5 million in Q2 2020.
• Historically, Gains from Investment Securities has averaged $13.8 million across 4 years, with a median of $192000.0 in 2020.
• Across the five-year window, Gains from Investment Securities plunged 292.56% in 2019 and surged 96150.0% in 2021, its largest moves.
• Year by year, Gains from Investment Securities stood at -$4.1 million in 2018, then soared by 148.87% to $2.0 million in 2019, then jumped by 122.84% to $4.5 million in 2020, then jumped by 4009.41% to $184.8 million in 2021.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were $184.8 million in Q3 2021, $2.6 million in Q2 2021, and $2.5 million in Q1 2021.